Suitability of gamma irradiated chitosan based membranes as matrix in drug release system

International Journal of Pharmaceutics

Volumn 395, Issue 1-2, 2010, Pages 142-146

  Casimiro, M H ^a,b   Gil, M H ^c   Leal, J P ^b,d  

^a DEPARTAMENTO DE QUÍMICA   (Portugal)

^b INSTITUTO TECNOLÓGICO E NUCLEAR   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF LISBON   (Portugal)

Author keywords

Antimicrobial activity; Chitosan; Drug release; Haemolysis; Radiation polymerization; Radiosterilization

Indexed keywords

2 HYDROXYETHYL METHACRYLATE; AMOXICILLIN; CHITOSAN; COBALT 60; ANTIINFECTIVE AGENT; ARTIFICIAL MEMBRANE; DELAYED RELEASE FORMULATION; DRUG CARRIER; METHACRYLIC ACID DERIVATIVE;

ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG DELIVERY SYSTEM; GAMMA IRRADIATION; HEMOLYSIS; MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; ANIMAL; ARTIFICIAL MEMBRANE; BANDAGE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; DRUG FORMULATION; GAMMA RADIATION; INSTRUMENT STERILIZATION; INTRADERMAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; PHARMACEUTICS; PROCEDURES; RABBIT; RADIATION RESPONSE; TOXICITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFECTIVE AGENTS; BANDAGES; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; GAMMA RAYS; HEMOLYSIS; MEMBRANES, ARTIFICIAL; METHACRYLATES; RABBITS; STERILIZATION; TECHNOLOGY, PHARMACEUTICAL;

EID: 77954312880     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.05.034     Document Type: Article

References (34)

1. Alemdaroglu C., Degim Z., Celebi N., Zor F., Ozturk S., Erdogan D. An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor. Burns 2006, 32:319-327.
2. Alves N.M., Mano J.F. Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications. Int. J. Biol. Macromol. 2008, 43:401-414.
3. ASTM Standard C 756-00 Standard Practice for Assessment of Haemolytic Properties of Materials 2000, ASTM International, Philadelphia.
4. Bayramoglu G., Arica M.Y. Procion Green H-4G immobilized on a new IPN hydrogel membrane composed of poly(2-hydroxyethylmethacrylate)/chitosan: preparation and its application to the adsorption of lysozyme. Colloids Surf. A 2002, 202:41-52.
5. Berger J., Reist M., Mayer J.M., Felt O., Peppas N.A., Gurny R. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm. 2004, 57:19-34.
6. Casimiro M.H., Botelho M.L., Leal J.P., Gil M.H. Chitosan graft copolymerisation induced by chemical, UV and gamma radiation. Radiat. Phys. Chem. 2005, 72:731-735.
7. Casimiro M.H., Leal J.P., Gil M.H. Characterisation of gamma irradiated chitosan/pHEMA membranes for biomedical purposes. Nucl. Instrum. Methods Phys. Res. B 2005, 236:482-487.
8. Casimiro M.H., Gil M.H., Leal J.P. Drug release assays from new chitosan/pHEMA membranes obtained by gamma irradiation. Nucl. Instrum. Methods Phys. Res. B 2007, 265:406-409.
9. Enescu D., Olteanu C.E. Functionalized chitosan and its use in pharmaceutical, biomedical, and biotechnological research. Chem. Eng. Commun. 2008, 195:1269-1291.
10. EN Standard 552 Sterilization of Medical Devices-Validation and Routine Control of Sterilization by Irradiation 1994.
11. Helander I.M., Nurmiaho-Lassila E.-L., Ahvenainen R., Rhoades J., Roller S. Chitosan disrupts the barrier properties of the outer membrane of Gram-negative bacteria. Int. J. Food Microbiol. 2001, 71:235-244.
12. Ishihara M., Nakanishi K., Ono K., Sato M., Kikuchi M., Saito Y., Yura H., Matsui T., Hattori H., Uenoyama M., Kurita A. Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials 2002, 23:833-840.
13. ISO 10993-4 Biological Evaluation of Medical Devices-Part 4: Selection of Tests for Interaction with Blood 1999, International Standards Organization.
14. ISO 11137 Sterilization of Health Care Products - Requirements for Validation and Routine Control - Radiation Sterilization 1995, International Standards Organization.
15. Jayakumar R., Prabaharan M., Nair S.V., Tamura H. Novel chitin and chitosan nanofibers in biomedical applications. Biotechnol. Adv. 2010, 28:142-150.
16. Khor E., Lim L.Y. Implantable applications of chitin and chitosan. Biomaterials 2003, 24:2339-2349.
17. Koide S.S. Chitin-chitosan: properties, benefits and risks. Nutr. Res. 1998, 18:1091-1101.
18. Lim L.Y., Khor E., Koo O. γ irradiation of chitosan. J. Biomed. Res. (Appl. Biomater.) 1998, 43:282-290.
19. Luyen D.V., Huong D.M. Chitin and derivatives. Polymeric Materials Encyclopedia 1996, 1208-1215. CRC, New York. J.C. Salamone (Ed.).
20. Madihally S.V., Matthew H.W.T. Porous chitosan scaffolds for tissue engineering. Biomaterials 1999, 20:1133-1142.
21. Muzzarelli R. Chitosan. Natural Chelating Polymers 1973, 144-176. Pergamon Press, Oxford. R. Muzzarelli (Ed.).
22. Muzzarelli R., Tarsi R., Filippini O., Giovanetti E., Biagini G., Varaldo P.E. Antimicrobial properties of N-carboxybutyl chitosan. Antimicrob. Agents Chemother. 1990, 34:2019-2023.
23. Ngoenkam J., Faikrua A., Yasothornsrikul S., Viyoch J. Potential of an injectable chitosan/starch/β-glycerol phosphate hydrogel for sustaining normal chondrocyte function. Int. J. Pharm. 2010, 391:115-124.
24. No H.K., Park N.Y., Lee S.H., Meyers S.P. Antimicrobial activity of chitosans and chitosan oligomers with different molecular weights. Int. J. Food Microbiol. 2002, 74:65-72.
25. Queiroz A.C., Santos J.D., Monteiro F.J., Gibson I.R., Knowles J.C. Adsorption and release studies of sodium ampicillin from hydroxyapatite and glass-reinforced hydroxyapatite composites. Biomaterials 2001, 22:1393-1400.
26. Risbud M.V., Hardikar A.A., Bhat S.V., Bhonde R.R. pH-sensitive freeze dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. J. Control. Rel. 2000, 68:23-30.
27. Sachdeva V., Siddoju S., Yu Y.-Y., Kim H.D., Friden P.M., Banga A.K. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin. Int. J. Pharm. 2010, 388:24-31.
28. Shi C., Zhu Y., Ran X., Wang M., Su Y., Cheng T. Therapeutic potential of chitosan and its derivatives in regenerative medicine. J. Surg. Res. 2006, 133:185-192.
29. Silverman, G.J., 1983. Sterilization by ionizing radiation. In: Block S.S. (Ed.), Disinfection, Sterilization and Preservation. Lea & Febiger, Philadelphia, p.94.
30. Singla A.K., Chawla M. Chitosan: some pharmaceutical and biological aspects-an update. J. Pharm. Pharmacol. 2001, 53:1047-1067.
31. Thein-Han W.W., Stevens W.F. Transdermal delivery controlled by a chitosan membrane. Drug Dev. Ind. Pharm. 2004, 30:397-404.
32. Torrado S., Prada P., de la Torre P.M., Torrado S. Chitosan-poly(acrylic) acid polyionic complex: in vivo study to demonstrate prolonged gastric retention. Biomaterials 2004, 25:917-923.
33. Valvo L., Manna L., Alimenti R., Alimonti S., Bertocchi P., Ciranni E. Amoxicillin sodium-potassium clavulanate: evaluation of gamma radiation induced effects by liquid chromatography on both the individual drugs and their combination. J. Pharm. Biomed. Anal. 1999, 21:9-14.
34. Whitby J.L. Microbiological aspects relating to the choice of radiation sterilization dose. Radiat. Phys. Chem. 1993, 42:577-580.